Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Nerdwallet Inc (NRDS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Nerdwallet Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Nerdwallet Inc trades at $9.81 (market cap $580.74M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 8.1× Nerdwallet Inc's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Nerdwallet Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Nerdwallet Inc for 45 Days on average.
| DFTX | NRDS | |
|---|---|---|
Market Cap | $4.71B | $580.74M |
Volume | 1,966,636 | 547,586 |
Sector | Health | Media |
52-Week High | $48.45 | $15.93 |
52-Week Low | $10.68 | $7.58 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $3.67B | $495.04M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NerdWallet (NRDS) trades at $9.085, up 2.54% with bullish technical signals from moving averages and oscillators. The company shows strong fundamentals with revenue growth from $539M in 2022 to $837M in 2025, improving net income from losses to $49M, and attractive valuation ratios including P/E of 10.09 and P/S of 0.76. Recent Q2 2026 earnings missed expectations at $0.07 per share versus $0.0934, but Q1 and Q4 2025 beat estimates.
Outlook remains positive with analyst consensus favoring Buy ratings (66.7%) and a projected 27.9% upside potential. Key risks include competitive pressures in credit cards and small-business products, reliance on organic search traffic, and macroeconomic sensitivity. The stock presents value with strong profitability margins and cash flow generation despite recent earnings volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Nerdwallet Inc
Nerdwallet Inc is a free tool to find you the best credit cards, cd rates, savings, checking accounts, scholarships, healthcare and airlines.
Read more on NRDS →
